Volume 7, Issue 6 , Pages 689-695, June 2009
Incidence, Prevalence, and Clinical Significance of Abnormal Hematologic Indices in Compensated Cirrhosis
Background & Aims
Patients with cirrhosis develop abnormal hematologic indices (HI) from multiple factors, including hypersplenism. We aimed to analyze the sequence of events and determine whether abnormal HI has prognostic significance.
Methods
We analyzed a database of 213 subjects with compensated cirrhosis without esophageal varices. Subjects were followed for approximately 9 years until the development of varices or variceal bleeding or completion of the study; 84 subjects developed varices. Abnormal HI was defined as anemia at baseline (hemoglobin, ≤13.5 g/dL for men and 11.5 g/dL for women), leukopenia (white blood cell counts, ≤4000/mm3), or thrombocytopenia (platelet counts, ≤150,000/mm3). The primary end points were death or transplant surgery.
Results
Most subjects had thrombocytopenia at baseline. Kaplan–Meier analysis showed that leukopenia occurred by 30 months (95% confidence interval, 18.5–53.6), and anemia occurred by 39.6 months (95% confidence interval, 24.1–49.9). Baseline thrombocytopenia (P = .0191) and leukopenia (P = .0383) were predictors of death or transplant, after adjusting for baseline hepatic venous pressure gradient (HVPG), and Child–Pugh scores. After a median of 5 years, a significant difference in death or transplant, mortality, and clinical decompensation was observed in patients who had leukopenia combined with thrombocytopenia at baseline compared with patients with normal HI (P < .0001). HVPG correlated with hemoglobin and white blood cell count (hemoglobin, r = −0.35, P < .0001; white blood cell count, r = −0.31, P < .0001).
Conclusions
Thrombocytopenia is the most common and first abnormal HI to occur in patients with cirrhosis, followed by leukopenia and anemia. A combination of leukopenia and thrombocytopenia at baseline predicted increased morbidity and mortality.
Abbreviations used in this paper: CI, confidence interval, GEV, gastroesophageal varices, Hgb, hemoglobin, HI, hematologic indices, HVPG, hepatic venous pressure gradient, WBC, white blood cell count
Conflicts of interest The authors disclose no conflicts.
Funding Supported by a grant (RO1 46580) from the National Institute of Diabetes and Digestive and Kidney Diseases and Goldberg Junior Faculty Award (7/1/06–6/30/08). The CIBERehd is funded by the Instituto de Salud Carlos III.
PII: S1542-3565(09)00200-6
doi:10.1016/j.cgh.2009.02.021
© 2009 AGA Institute. Published by Elsevier Inc. All rights reserved.
Volume 7, Issue 6 , Pages 689-695, June 2009


